Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Tsumura & Co.    4540   JP3535800001

TSUMURA & CO.

(4540)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (JPY)
Sales 2020 125 B
EBIT 2020 19 267 M
Net income 2020 14 133 M
Finance 2020 25 941 M
Yield 2020 2,02%
Sales 2021 128 B
EBIT 2021 20 000 M
Net income 2021 14 700 M
Finance 2021 31 051 M
Yield 2021 2,06%
P/E ratio 2020 17,2x
P/E ratio 2021 16,5x
EV / Sales2020 1,73x
EV / Sales2021 1,65x
Capitalization 243 B
More Financials
Company
TSUMURA & CO. is a Japan-based company mainly engaged in the manufacture and sale of ethical and general pharmaceuticals. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and... 
Sector
Pharmaceuticals
Calendar
02/07Earnings Release
More about the company
Surperformance© ratings of Tsumura & Co.
Trading Rating : Investor Rating :
More Ratings
Latest news on TSUMURA & CO.
09/27TSUMURA & CO : Ex-dividend day for interim dividend
FA
03/27TSUMURA & CO : Ex-dividend day for final dividend
FA
2018TSUMURA & CO : Ex-dividend day for interim dividend
FA
2018TSUMURA & CO : Ex-dividend day for final dividend
FA
2017TSUMURA & CO : Ex-dividend day for interim dividend
FA
2017TSUMURA & CO : Ex-dividend day for final dividend
FA
2016TSUMURA & CO : Ex-dividend day for interim dividend
FA
2016TSUMURA & CO : annual earnings release
2016TSUMURA & CO : Ex-dividend day for final dividend
FA
2015TSUMURA & CO : Ex-dividend day for interim dividend
FA
2015TSUMURA & CO : Ex-dividend day for final dividend
FA
2014TSUMURA & CO : Ex-dividend day for interim dividend
FA
2014TSUMURA & CO. : Ex-dividend day for final dividend
FA
2013TSUMURA & CO. : Ex-dividend day for interim dividend
FA
2013TSUMURA & CO. : quaterly earnings release
More news
News in other languages on TSUMURA & CO.
09/27TSUMURA & CO : Ex-dividend day for interim dividend
03/27TSUMURA & CO : Ex-dividend day for final dividend
2018TSUMURA & CO : Ex-dividend day for interim dividend
2018TSUMURA & CO : Ex-dividend day for final dividend
2017TSUMURA & CO : Ex-dividend day for interim dividend
More news
Analyst Recommendations on TSUMURA & CO.
More recommendations
Sector news : Pharmaceuticals - NEC
12/13EAGLE PHARMACEUTICALS : Pharma Shares up After It Says Settlement Reached With E..
DJ
12/13BRISTOL MYERS SQUIBB : Myers Executive VP Elicker to Retire; CVS's Metcalfe Taki..
DJ
12/13DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
12/13ALLERGAN : Form 8.3 -
DJ
12/13ABBVIE : Form 8.3 -
DJ
More sector news : Pharmaceuticals - NEC
Technical analysis trends TSUMURA & CO.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 3 333,33  JPY
Last Close Price 3 175,00  JPY
Spread / Highest target 7,09%
Spread / Average Target 4,99%
Spread / Lowest Target 3,94%
EPS Revisions
Managers
NameTitle
Terukazu Kato Executive President & Representative Director
Yasunori Fuji Director & Senior Manager-Compliance
Kimikazu Okochi Director
Shigeru Sugimoto Independent Outside Director
Kenichi Matsui Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
TSUMURA & CO.6.37%2 224
JOHNSON & JOHNSON9.52%372 094
ROCHE HOLDING AG24.22%261 287
MERCK AND COMPANY16.73%227 076
PFIZER-12.19%212 123
NOVARTIS22.85%210 097